Chemotherapy Biotherapy Certification ONS Practice Testq

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the ONS Chemotherapy Biotherapy Certification Exam. Leverage flashcards and multiple choice questions, complete with hints and explanations. Equip yourself for exam success!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

What type of cancer can chemotherapy agents specifically be used to sensitize?

Breast cancer
Colorectal cancer
Prostate cancer
Skin cancer

The correct answer is: Colorectal cancer

Chemotherapy agents can specifically be used to sensitize colorectal cancer due to the nature of the disease and the pharmacological properties of certain chemotherapeutic drugs. Colorectal cancer often requires a combination of treatment approaches, including surgery, radiation, and chemotherapy. The use of chemotherapy agents aims to enhance the effectiveness of other treatments and reduce the likelihood of metastasis. In colorectal cancer, drugs like fluorouracil and leucovorin are commonly used in combination regimens, and they can make cancer cells more susceptible to the effects of radiation therapy or other forms of treatment. This sensitization allows for a more aggressive approach to targeting the cancer and improving outcomes for patients with this type of malignancy. Additionally, recent advancements in biomarker identification have furthered the understanding of how certain chemotherapy agents can be effectively combined to optimize treatment responses in colorectal cancer patients. Understanding the specific role of chemotherapy in sensitizing colorectal cancer helps clinicians tailor their treatment plans to maximize effectiveness and improve the prognosis for their patients.